383 related articles for article (PubMed ID: 22833515)
1. Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction.
Reil JC; Hohl M; Reil GH; Granzier HL; Kratz MT; Kazakov A; Fries P; Müller A; Lenski M; Custodis F; Gräber S; Fröhlig G; Steendijk P; Neuberger HR; Böhm M
Eur Heart J; 2013 Sep; 34(36):2839-49. PubMed ID: 22833515
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
Milliez P; Messaoudi S; Nehme J; Rodriguez C; Samuel JL; Delcayre C
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H435-41. PubMed ID: 19074674
[TBL] [Abstract][Full Text] [Related]
3. Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction.
Borlaug BA; Lam CS; Roger VL; Rodeheffer RJ; Redfield MM
J Am Coll Cardiol; 2009 Jul; 54(5):410-8. PubMed ID: 19628115
[TBL] [Abstract][Full Text] [Related]
4. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.
Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F
Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862
[TBL] [Abstract][Full Text] [Related]
5. Low-sodium DASH diet improves diastolic function and ventricular-arterial coupling in hypertensive heart failure with preserved ejection fraction.
Hummel SL; Seymour EM; Brook RD; Sheth SS; Ghosh E; Zhu S; Weder AB; Kovács SJ; Kolias TJ
Circ Heart Fail; 2013 Nov; 6(6):1165-71. PubMed ID: 23985432
[TBL] [Abstract][Full Text] [Related]
6. Novel drugs for heart rate control in heart failure.
Bielecka-Dabrowa A; von Haehling S; Rysz J; Banach M
Heart Fail Rev; 2018 Jul; 23(4):517-525. PubMed ID: 29594814
[TBL] [Abstract][Full Text] [Related]
7. Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients.
Reil JC; Tardif JC; Ford I; Lloyd SM; O'Meara E; Komajda M; Borer JS; Tavazzi L; Swedberg K; Böhm M
J Am Coll Cardiol; 2013 Nov; 62(21):1977-1985. PubMed ID: 23933545
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
Alex L; Russo I; Holoborodko V; Frangogiannis NG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
[TBL] [Abstract][Full Text] [Related]
9. Ivabradine Ameliorates Cardiac Function in Heart Failure with Preserved and Reduced Ejection Fraction via Upregulation of miR-133a.
Shao S; Zhang Y; Gong M; Yang Q; Yuan M; Yuan M; Suo Y; Wang X; Li Y; Bao Q; Li G
Oxid Med Cell Longev; 2021; 2021():1257283. PubMed ID: 34630844
[TBL] [Abstract][Full Text] [Related]
10. Metformin improves diastolic function in an HFpEF-like mouse model by increasing titin compliance.
Slater RE; Strom JG; Methawasin M; Liss M; Gotthardt M; Sweitzer N; Granzier HL
J Gen Physiol; 2019 Jan; 151(1):42-52. PubMed ID: 30567709
[TBL] [Abstract][Full Text] [Related]
11. Characterization of static and dynamic left ventricular diastolic function in patients with heart failure with a preserved ejection fraction.
Prasad A; Hastings JL; Shibata S; Popovic ZB; Arbab-Zadeh A; Bhella PS; Okazaki K; Fu Q; Berk M; Palmer D; Greenberg NL; Garcia MJ; Thomas JD; Levine BD
Circ Heart Fail; 2010 Sep; 3(5):617-26. PubMed ID: 20682947
[TBL] [Abstract][Full Text] [Related]
12. Ventricular-vascular dynamics in pediatric patients with heart failure and preserved ejection fraction.
Masutani S; Kuwata S; Kurishima C; Iwamoto Y; Saiki H; Sugimoto M; Ishido H; Senzaki H
Int J Cardiol; 2016 Dec; 225():306-312. PubMed ID: 27744267
[TBL] [Abstract][Full Text] [Related]
13. Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction.
Edwards NC; Ferro CJ; Townend JN; Steeds RP
Heart; 2008 Aug; 94(8):1038-43. PubMed ID: 18308865
[TBL] [Abstract][Full Text] [Related]
14. Left Atrial Remodeling and Atrioventricular Coupling in a Canine Model of Early Heart Failure With Preserved Ejection Fraction.
Zakeri R; Moulay G; Chai Q; Ogut O; Hussain S; Takahama H; Lu T; Wang XL; Linke WA; Lee HC; Redfield MM
Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27758811
[TBL] [Abstract][Full Text] [Related]
15. Effects of selective heart rate reduction with ivabradine on LV function and central hemodynamics in patients with chronic coronary syndrome.
Hohneck AL; Fries P; Stroeder J; Schneider G; Schirmer SH; Reil JC; Böhm M; Laufs U; Custodis F
Int J Cardiol Heart Vasc; 2021 Jun; 34():100757. PubMed ID: 33851006
[TBL] [Abstract][Full Text] [Related]
16. Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function In a Mouse Model of Heart Failure With Preserved Ejection Fraction.
Methawasin M; Strom JG; Slater RE; Fernandez V; Saripalli C; Granzier H
Circulation; 2016 Oct; 134(15):1085-1099. PubMed ID: 27630136
[TBL] [Abstract][Full Text] [Related]
17. Load-Independent Systolic and Diastolic Right Ventricular Function in Heart Failure With Preserved Ejection Fraction as Assessed by Resting and Handgrip Exercise Pressure-Volume Loops.
Rommel KP; von Roeder M; Oberueck C; Latuscynski K; Besler C; Blazek S; Stiermaier T; Fengler K; Adams V; Sandri M; Linke A; Schuler G; Thiele H; Lurz P
Circ Heart Fail; 2018 Feb; 11(2):e004121. PubMed ID: 29449367
[TBL] [Abstract][Full Text] [Related]
18. Rationale and Design of the Multicenter Trial on Japan Working Group on the Effects of Angiotensin Receptor Blockers Selection (Azilsartan vs. Candesartan) on Diastolic Function in the Patients Suffering from Heart Failure with Preserved Ejection Fraction: J-TASTE Trial.
Takahama H; Asakura M; Abe Y; Ajioka M; Aonuma K; Anzai T; Hayashi T; Hiramitsu S; Kawai H; Kioka H; Kimura K; Lim YJ; Matsuoka K; Motoki H; Nagata Y; Nakamura S; Ohte N; Ozaki Y; Sasaoka T; Tamaki S; Hamasaki T; Kitakaze M;
Cardiovasc Drugs Ther; 2018 Aug; 32(4):381-388. PubMed ID: 29974299
[TBL] [Abstract][Full Text] [Related]
19. Role of heart rate reduction in the prevention of experimental heart failure: comparison between If-channel blockade and β-receptor blockade.
Becher PM; Lindner D; Miteva K; Savvatis K; Zietsch C; Schmack B; Van Linthout S; Westermann D; Schultheiss HP; Tschöpe C
Hypertension; 2012 May; 59(5):949-57. PubMed ID: 22493071
[TBL] [Abstract][Full Text] [Related]
20. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
